tiprankstipranks
Trending News
More News >
CSPC Pharmaceutical Group Limited (CHJTF)
OTHER OTC:CHJTF
US Market

CSPC Pharmaceutical Group (CHJTF) Ratios

Compare
27 Followers

CSPC Pharmaceutical Group Ratios

CHJTF's free cash flow for Q2 2025 was ¥0.66. For the 2025 fiscal year, CHJTF's free cash flow was decreased by ¥ and operating cash flow was ¥0.24. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.24 2.27 2.63 2.67 2.81
Quick Ratio
1.95 1.95 2.32 2.39 2.47
Cash Ratio
0.75 0.66 1.18 1.15 1.28
Solvency Ratio
0.50 0.52 0.62 0.66 0.71
Operating Cash Flow Ratio
0.68 0.44 0.41 0.92 0.66
Short-Term Operating Cash Flow Coverage
27.72 11.56 9.28 27.80 0.00
Net Current Asset Value
¥ 11.47B¥ 12.09B¥ 15.48B¥ 13.90B¥ 15.50B
Leverage Ratios
Debt-to-Assets Ratio
0.01 0.01 0.02 0.01 <0.01
Debt-to-Equity Ratio
0.01 0.01 0.02 0.02 <0.01
Debt-to-Capital Ratio
0.01 0.01 0.02 0.02 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 <0.01 0.00
Financial Leverage Ratio
1.38 1.38 1.39 1.38 1.34
Debt Service Coverage Ratio
20.81 13.57 15.16 19.64 852.96
Interest Coverage Ratio
191.41 124.82 296.58 272.69 814.87
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 0.00
Interest Debt Per Share
0.05 0.05 0.06 0.05 0.01
Net Debt to EBITDA
-1.05 -0.87 -1.33 -1.26 -1.21
Profitability Margins
Gross Profit Margin
66.72%69.97%70.51%71.94%75.84%
EBIT Margin
19.31%19.69%21.43%24.08%24.52%
EBITDA Margin
24.68%24.30%24.66%24.06%27.62%
Operating Profit Margin
16.35%18.45%22.20%21.94%22.41%
Pretax Profit Margin
18.95%19.23%21.36%24.56%24.49%
Net Profit Margin
14.95%14.92%16.98%16.93%16.69%
Continuous Operations Profit Margin
14.97%14.96%17.55%19.73%16.94%
Net Income Per EBT
78.86%77.58%79.48%68.94%68.15%
EBT Per EBIT
115.91%104.21%96.21%111.94%109.28%
Return on Assets (ROA)
8.85%9.33%12.69%12.99%13.19%
Return on Equity (ROE)
12.42%12.84%17.69%17.97%17.63%
Return on Capital Employed (ROCE)
12.40%14.74%21.27%21.43%22.36%
Return on Invested Capital (ROIC)
9.71%11.33%17.20%17.39%18.54%
Return on Tangible Assets
9.44%9.93%13.39%13.77%13.49%
Earnings Yield
4.17%7.85%7.52%6.20%5.54%
Efficiency Ratios
Receivables Turnover
2.88 2.97 3.24 4.72 4.21
Payables Turnover
3.96 3.39 3.59 5.02 5.00
Inventory Turnover
3.16 2.66 3.25 3.52 2.67
Fixed Asset Turnover
2.00 2.12 2.97 2.92 2.87
Asset Turnover
0.59 0.63 0.75 0.77 0.79
Working Capital Turnover Ratio
2.20 2.00 2.06 2.05 2.45
Cash Conversion Cycle
150.05 152.34 123.34 108.38 150.28
Days of Sales Outstanding
126.56 122.80 112.71 77.35 86.78
Days of Inventory Outstanding
115.66 137.07 112.29 103.72 136.50
Days of Payables Outstanding
92.17 107.53 101.67 72.68 73.00
Operating Cycle
242.22 259.87 225.00 181.07 223.28
Cash Flow Ratios
Operating Cash Flow Per Share
0.60 0.39 0.35 0.68 0.49
Free Cash Flow Per Share
0.13 0.16 0.19 0.45 0.31
CapEx Per Share
0.06 0.23 0.16 0.23 0.18
Free Cash Flow to Operating Cash Flow
0.22 0.41 0.55 0.66 0.64
Dividend Paid and CapEx Coverage Ratio
2.75 0.73 0.90 1.65 1.41
Capital Expenditure Coverage Ratio
10.66 1.69 2.21 2.91 2.77
Operating Cash Flow Coverage Ratio
13.86 8.94 5.91 14.10 50.96
Operating Cash Flow to Sales Ratio
0.25 0.15 0.12 0.26 0.17
Free Cash Flow Yield
1.52%3.31%2.93%6.17%3.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
23.99 12.73 13.30 16.13 18.06
Price-to-Sales (P/S) Ratio
3.58 1.90 2.26 2.73 3.01
Price-to-Book (P/B) Ratio
2.94 1.63 2.35 2.90 3.18
Price-to-Free Cash Flow (P/FCF) Ratio
65.73 30.23 34.17 16.22 27.05
Price-to-Operating Cash Flow Ratio
14.23 12.37 18.69 10.65 17.27
Price-to-Earnings Growth (PEG) Ratio
-4.44 -0.53 -2.30 -1.77 1.11
Price-to-Fair Value
2.94 1.63 2.35 2.90 3.18
Enterprise Value Multiple
13.47 6.94 7.83 10.09 9.70
Enterprise Value
90.45B 49.84B 66.79B 76.71B 90.00B
EV to EBITDA
13.46 6.94 7.83 10.09 9.70
EV to Sales
3.32 1.69 1.93 2.43 2.68
EV to Free Cash Flow
60.95 26.86 29.22 14.42 24.04
EV to Operating Cash Flow
13.18 10.99 15.98 9.47 15.35
Tangible Book Value Per Share
2.80 2.83 2.74 2.44 2.69
Shareholders’ Equity Per Share
2.91 2.92 2.80 2.50 2.66
Tax and Other Ratios
Effective Tax Rate
0.21 0.22 0.18 0.18 0.17
Revenue Per Share
2.38 2.52 2.91 2.65 2.81
Net Income Per Share
0.36 0.38 0.49 0.45 0.47
Tax Burden
0.79 0.78 0.79 0.69 0.68
Interest Burden
0.98 0.98 1.00 1.02 1.00
Research & Development to Revenue
0.20 0.18 0.15 0.13 0.12
SG&A to Revenue
0.02 0.00 0.04 0.03 0.03
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.64 0.98 0.57 1.30 0.87
Currency in CNY